Navigation Links
Proposed $350 Million Class Action Settlement Regarding Drug Pricing Provides Consumers and Third-Party Payors With Money Back

WASHINGTON, April 23 /PRNewswire-USNewswire/ -- The United States District Court for the District of Massachusetts has preliminarily approved the settlement of a class action with McKesson, a large drug wholesaler. The lawsuit, called New England Carpenters Health Benefits Fund v. First DataBank, Inc., concerns the pricing of more than 450 brand-name drugs, and consumers and Third-Party Payors ("TPPs") could get money back.

Prescription drugs are often priced using certain benchmarks. The most common pricing benchmark is sometimes called the Average Wholesale Price, or "AWP." AWP is often used in determining how much insurance companies will reimburse for these prescription drugs and the co-payment price that some consumers pay for them. The lawsuit claims that two Defendants, McKesson and First DataBank, a publisher of drug data, wrongfully inflated the mark-up factor used to determine the AWP of over 450 drugs. The lawsuit alleges that, as a result, many drug purchasers overpaid for these drugs. FDB and McKesson deny any wrongdoing.

McKesson has agreed to settle the claims against it and will pay a total of $350 million into a Settlement Fund to benefit a class of consumers and non-governmental Third-Party Payors with up to $60 million allocated to consumer Class Members alone.

Included in the McKesson Proposed Settlement are consumers who paid percentage co-payments for any of the settlement drugs between August 2, 2001 and March 15, 2005; uninsured or underinsured consumers who paid the cash price of any of the settlement drugs between August 1, 2001 and January 23, 2009; and TPPs that paid or reimbursed for all or a part of the cost of any settlement drug from August 2001 to March 15, 2005. TPPs include, but are not limited to, insurance companies, health plans, union health and welfare plans, and self-insured employers.

Potential members of the class of TPPs and consumers who paid a percentage co-payment were previously notified of the pending trial against McKesson and had until November 15, 2008 to exclude themselves from the Class. Class Members who did not exclude themselves are included in the Proposed Settlement and will be bound by the Court's rulings. Uninsured or underinsured consumers who paid the cash price of settlement drugs may exclude themselves and will not get money back but will keep their rights to sue McKesson at their own expense. A request for exclusion must be in writing by June 8, 2009. The Court will determine whether to approve the McKesson Proposed Settlement at a Fairness Hearing on July 23, 2009 at 2 p.m.

"The McKesson Proposed Settlement will allow consumers and TPPs to receive some money back in the near future if they file a claim," said Steve W. Berman of Hagens Berman Sobol Shapiro LLP, Counsel for the Plaintiffs in this case.

For detailed information and a list of all the drugs included, call toll-free 1-877-625-9414, visit, email or write: McKesson Settlement Administrator c/o Rust Consulting, Inc, PO Box 24607, West Palm Beach, FL 33416.

SOURCE McKesson Settlement Administrator
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Avoiding No Mans Land: New Deloitte Study on Follow-on Biologics Investigates Proposed Legislation and Possible Unintended Consequences
2. White House Protest Denouncing Obamas Speech at Notre Dame and Proposed Change in Abortion Conscience Regs.
3. Proposed Settlement Will Make Up to $28 Million Available to Individuals Who Purchased and Companies That Reimbursed for Paxil CR(R)
4. American College of Surgeons Supports Steps to Shore Up Medicare Payment System In Proposed Federal Budget
5. MGT Capital Investments, Inc.: Failure to Satisfy a Continued Listing Rule Based on a Lack of Shareholder Meeting in 2008 and Medicsight Statement Regarding CMS Proposed Decision
6. Advocates Call on Legislature to Stop Proposed Rx Cuts to the Elderly and Poor
7. Courage Center Experts Disagree With Gov. Pawlentys Proposed Budget Cuts
8. Endocare Announces Filing of Form S-4 Registration Statement Related to Proposed Merger With Galil Medical
9. Johnson & Johnson Announces Satisfaction of Regulatory Clearances Condition for its Proposed Acquisition of Mentor Corporation
10. Healthcare Organizations Launch Collaborative Initiative to Test HIPAA Transactions Against Proposed 5010 Standards
11. Biopure Submits IND Application for Proposed Clinical Trial in Patients with Acute Myeloid Leukemia
Post Your Comments:
(Date:11/30/2015)... ... , ... According to Los Angeles bariatric surgeon Michael Feiz, M.D., F.A.C.S., many ... real hunger, but instead by a hormone called ghrelin which (often prematurely) signals ... are aware that weight loss surgery can help patients lose weight by restricting the ...
(Date:11/30/2015)... Miami, FL (PRWEB) , ... November 30, 2015 ... ... added a comparison chart and ingredient list of its hemorrhoid ointment to its ... “fast, effective pain relief for people suffering from hemorrhoids. Adding the comparison chart ...
(Date:11/30/2015)... ... November 30, 2015 , ... Using a combination of two blood sugar tests ... adults, according to a new study by researchers at the School of Public Health ... Adults: Using Combinations of Blood Glucose Tests ,” published in Frontiers in Public Health, ...
(Date:11/30/2015)... ... November 30, 2015 , ... The recently ... Poison Data System (NPDS) reveals that in 2014, someone called a poison center ... two million of which were human exposure cases. , The American Association of ...
(Date:11/30/2015)... Reading, PA (PRWEB) , ... November 30, 2015 ... ... Ashland Specialty Ingredients (ASI) as their exclusive channel partner for the Nutraceutical Specialties ... supplements markets in the US, effective immediately. , “We are pleased to ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Next week, December 2-3, BIOMEDevice San ... co-located events covering the latest in Medtech innovation, Wearable ... draw more than 3,000 design industry professionals to the ... events, combined show floor will host more than 300 ... --> --> BIOMEDevice features suppliers in ...
(Date:11/30/2015)...  IBA Molecular North America, Inc. (IBAMNA), a U.S. ... that as of January 1, 2016, it will do ... to rebrand the company reflects a refined vision for ... close relationship with Zevacor Molecular.  Both IBAMNA and Zevacor ... Peter Burke , Vice President Sales ...
(Date:11/30/2015)... , Nov. 30, 2015 Nautilus Medical Inc. ... Image Management platform ( ). The release of ... from RSNA 2015 (Radiology Society North America) in ... in the U.S. --> ... that enables access to radiology studies worldwide via a ...
Breaking Medicine Technology: